Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey
European Journal of Clinical Pharmacology · 2024
DOI: 10.1007/s00228-024-03729-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Mohammed Gebre Dedefo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia. mohamm…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Health Knowledge, Attitudes, Practice, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of South Australia.
Abstract (Originalsprache)
This study aimed to investigate the current knowledge and experiences of consumers in Australia on adverse drug reaction (ADR) reporting and their reasons for reporting or not reporting ADRs, with a focus on the use of digital tools for ADR reporting.
Methods
A cross-sectional online survey was conducted among adults who had taken medicine in Australia. A structured questionnaire with multiple choice or Likert scale responses with an option for participants to provide free-text responses and pretested for face validity was used. Consumer characteristics, knowledge, and ADR reporting practices were analyzed using descriptive statistics and the chi-square test or Fisher’s exact test.
Results
A total of 544 survey responses were included in the analysis. The majority of respondents were women (68%), and 22% were aged between 65 and 74 years. Fifty-eight percent ( n = 317) of respondents knew that they could report ADRs to either the Therapeutic Goods Administration (TGA), state or territory government health department, or healthcare professionals. Three-quarters ( n = 405) of respondents stated that they had experienced an ADR; of these, 36% reported an ADR to either the TGA, state or territory government health department, or healthcare professionals. Among those who reported ADRs, 58% were unaware that they could use digital tools to report ADRs. The main reason for not reporting was that they did not think the ADR was serious enough to report (39%).
Conclusion
Over half of consumers knew that they could report ADR; however, improved consumer awareness about using digital tools for ADR reporting and increased ADR reporting is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia. mohammed_gebre.dedefo@mymail.unisa.edu.au.
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Förderung
- National Health and Medical Research Council
- University of South Australia
Zitieren
APA
Dedefo, M. G., Lim, R., Kassie, G. M., Roughead, E., & Ellett, L. K. (2024). Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03729-y
Vancouver
Dedefo MG, Lim R, Kassie GM, Roughead E, Ellett LK. Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03729-y
BibTeX
@article{Dedefo2024,
author = {Dedefo, Mohammed Gebre and Lim, Renly and Kassie, Gizat M and Roughead, Elizabeth and Ellett, Lisa Kalisch},
title = {Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey},
journal = {European Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1007/s00228-024-03729-y}
}
EUVIMED